These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6189669)
1. The influence of normal guinea-pig serum and tissue culture assay system on foot-and-mouth disease virus neutralisation. Ferris NP; Donaldson AI Comp Immunol Microbiol Infect Dis; 1983; 6(2):161-9. PubMed ID: 6189669 [TBL] [Abstract][Full Text] [Related]
2. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Dunn CS; Samuel AR; Pullen LA; Anderson J Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571 [TBL] [Abstract][Full Text] [Related]
3. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus. Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628 [TBL] [Abstract][Full Text] [Related]
4. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. Hamblin C; Barnett IT; Hedger RS J Immunol Methods; 1986 Oct; 93(1):115-21. PubMed ID: 3021854 [TBL] [Abstract][Full Text] [Related]
5. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies. Wagner GG; Cown KM J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129 [No Abstract] [Full Text] [Related]
6. Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes. Garmendia AE; Borca MV; Morgan DO; Baxt B J Immunol; 1989 Nov; 143(9):3015-9. PubMed ID: 2553817 [TBL] [Abstract][Full Text] [Related]
7. Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization. Rweyemamu MM; Booth JC; Pay TW J Hyg (Lond); 1977 Feb; 78(1):99-112. PubMed ID: 13123 [TBL] [Abstract][Full Text] [Related]
8. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application. van Maanen C Vet Microbiol; 1990 Aug; 24(2):179-91. PubMed ID: 2173249 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit. Hardy MM; Moore DM J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797 [TBL] [Abstract][Full Text] [Related]
10. [Serologic study of 2 strains of foot-and-mouth virus, cultured in cell line IB-RS-2, clone 26-3]. Abuhab TG; Pinto AA Arq Inst Biol (Sao Paulo); 1978; 45(1):7-12. PubMed ID: 224836 [TBL] [Abstract][Full Text] [Related]
11. A study of foot-and-mouth disease virus strains by complement fixation. I. A model for the fixation of complement by antigen-antibody mixtures. Forman AJ J Hyg (Lond); 1974 Jun; 72(3):397-405. PubMed ID: 4367223 [TBL] [Abstract][Full Text] [Related]
12. A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus. Forman AJ J Hyg (Lond); 1975 Apr; 74(2):215-25. PubMed ID: 164500 [TBL] [Abstract][Full Text] [Related]
13. Detection of foot-and-mouth disease virus antibody using counterimmunoelectrophoresis and serum neutralisation tests. Rao MV; Suryanarayana VV; Bhanumati N; Rao DR; Madhusudan P; Rao BU Trop Anim Health Prod; 1985 May; 17(2):89-92. PubMed ID: 2992139 [TBL] [Abstract][Full Text] [Related]
14. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. Hamblin C; Barnett IT; Crowther JR J Immunol Methods; 1986 Oct; 93(1):123-9. PubMed ID: 3021855 [TBL] [Abstract][Full Text] [Related]
15. The detection of antibodies against foot-and-mouth disease virus (FMDV) in filter paper eluates from pig sera or whole blood by ELISA. Armstrong RM; Crowther JR; Denyer MS J Virol Methods; 1991; 34(2):181-92. PubMed ID: 1666636 [TBL] [Abstract][Full Text] [Related]
16. The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction. Rweyemamu MM; Ouldridge EJ; Head M; Ferrari R J Biol Stand; 1984 Jul; 12(3):295-303. PubMed ID: 6090465 [TBL] [Abstract][Full Text] [Related]
17. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948 [TBL] [Abstract][Full Text] [Related]
18. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. Cartwright B; Chapman WG; Brown F J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of foot-and-mouth disease virus: further studies on plaque formation by two plaque-size variants. Martinsen JS Can J Comp Med; 1972 Jan; 36(1):26-33. PubMed ID: 4334291 [TBL] [Abstract][Full Text] [Related]
20. FURTHER STUDIES OF THE EARLY ANTIBODY IN THE SEA OF CATTLE AND GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. BROWN F; CARTWRIGHT B; NEWMAN JF J Immunol; 1964 Sep; 93():397-402. PubMed ID: 14218596 [No Abstract] [Full Text] [Related] [Next] [New Search]